BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24913706)

  • 61. Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer.
    Widschwendter M; Berger J; Hermann M; Müller HM; Amberger A; Zeschnigk M; Widschwendter A; Abendstein B; Zeimet AG; Daxenbichler G; Marth C
    J Natl Cancer Inst; 2000 May; 92(10):826-32. PubMed ID: 10814678
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Epigenetic alterations of adenomatous polyposis coli (APC), retinoic acid receptor beta (RARβ) and survivin genes in tumor tissues and voided urine of bladder cancer patients.
    Berrada N; Amzazi S; Ameziane El Hassani R; Benbacer L; El Mzibri M; Khyatti M; Chafiki J; Abbar M; Al Bouzidi A; Ameur A; Attaleb M
    Cell Mol Biol (Noisy-le-grand); 2012 Sep; Suppl.58():OL1744-51. PubMed ID: 22992440
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impact of catechol-O-methyltransferase gene variants on methylation status of P16 and MGMT genes and their downregulation in colorectal cancer.
    Wani HA; Majid S; Bhat AA; Amin S; Farooq R; Bhat SA; Naikoo NA; Beigh MA; Kadla SA
    Eur J Cancer Prev; 2019 Mar; 28(2):68-75. PubMed ID: 30379684
    [TBL] [Abstract][Full Text] [Related]  

  • 64. LINE-1 hypomethylation level as a potential prognostic factor for epithelial ovarian cancer.
    Pattamadilok J; Huapai N; Rattanatanyong P; Vasurattana A; Triratanachat S; Tresukosol D; Mutirangura A
    Int J Gynecol Cancer; 2008; 18(4):711-7. PubMed ID: 17944913
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Retinoic acid receptor beta2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells.
    Zhang Z; Joh K; Yatsuki H; Zhao W; Soejima H; Higashimoto K; Noguchi M; Yokoyama M; Iwasaka T; Mukai T
    Cancer Lett; 2007 Mar; 247(2):318-27. PubMed ID: 16806674
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Promoter methylation in the PTCH gene in cervical epithelial cancer and ovarian cancer tissue as studied by eight novel Pyrosequencing® assays.
    Löf-Öhlin ZM; Levanat S; Sabol M; Sorbe B; Nilsson TK
    Int J Oncol; 2011 Mar; 38(3):685-92. PubMed ID: 21206974
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
    Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
    World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Methylation of the retinoid response gene TIG1 in prostate cancer correlates with methylation of the retinoic acid receptor beta gene.
    Zhang J; Liu L; Pfeifer GP
    Oncogene; 2004 Mar; 23(12):2241-9. PubMed ID: 14691453
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Promoter methylation status and expression of TMS1 gene in human epithelial ovarian cancer.
    Akahira J; Sugihashi Y; Ito K; Niikura H; Okamura K; Yaegashi N
    Cancer Sci; 2004 Jan; 95(1):40-3. PubMed ID: 14720325
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Methylation and messenger RNA expression of p15INK4b but not p16INK4a are independent risk factors for ovarian cancer.
    Liu Z; Wang LE; Wang L; Lu KH; Mills GB; Bondy ML; Wei Q
    Clin Cancer Res; 2005 Jul; 11(13):4968-76. PubMed ID: 16000597
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.
    Lindsey JC; Lusher ME; Anderton JA; Bailey S; Gilbertson RJ; Pearson AD; Ellison DW; Clifford SC
    Carcinogenesis; 2004 May; 25(5):661-8. PubMed ID: 14688019
    [TBL] [Abstract][Full Text] [Related]  

  • 72. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
    Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
    Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
    Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
    BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Promoter methylation and loss of p16(INK4a) gene expression in head and neck cancer.
    Demokan S; Chuang A; Suoğlu Y; Ulusan M; Yalnız Z; Califano JA; Dalay N
    Head Neck; 2012 Oct; 34(10):1470-5. PubMed ID: 22106032
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association of low p16INK4a and p15INK4b mRNAs expression with their CpG islands methylation with human hepatocellular carcinogenesis.
    Qin Y; Liu JY; Li B; Sun ZL; Sun ZF
    World J Gastroenterol; 2004 May; 10(9):1276-80. PubMed ID: 15112341
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion.
    Katayama H; Hiraki A; Aoe K; Fujiwara K; Matsuo K; Maeda T; Murakami T; Toyooka S; Sugi K; Ueoka H; Tanimoto M
    Int J Cancer; 2007 May; 120(10):2191-5. PubMed ID: 17285579
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Aberrant protein expression and promoter methylation of p16 gene are correlated with malignant transformation of salivary pleomorphic adenoma.
    Hu YH; Zhang CY; Tian Z; Wang LZ; Li J
    Arch Pathol Lab Med; 2011 Jul; 135(7):882-9. PubMed ID: 21732778
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A novel genome-based approach correlates TMPRSS3 overexpression in ovarian cancer with DNA hypomethylation.
    Guerrero K; Wang Z; Bachvarova M; Gregoire J; Renaud MC; Plante M; Bachvarov D
    Gynecol Oncol; 2012 Jun; 125(3):720-6. PubMed ID: 22446619
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Aberrant promoter methylation and reduced expression of p16 gene in esophageal squamous cell carcinoma from Kashmir valley: a high-risk area.
    Salam I; Hussain S; Mir MM; Dar NA; Abdullah S; Siddiqi MA; Lone RA; Zargar SA; Sharma S; Hedau S; Basir SF; Bharti AC; Das BC
    Mol Cell Biochem; 2009 Dec; 332(1-2):51-8. PubMed ID: 19513816
    [TBL] [Abstract][Full Text] [Related]  

  • 80. p16 overexpression: a potential early indicator of transformation in ovarian carcinoma.
    Shigemasa K; Hu C; West CM; Clarke J; Parham GP; Parmley TH; Korourian S; Baker VV; O'Brien TJ
    J Soc Gynecol Investig; 1997; 4(2):95-102. PubMed ID: 9101469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.